56 F
New York
Friday, November 27, 2020

Renewed Optimism is Surrounding Synchrony Financial (NYSE:SYF)

Must read

Evofem Biosciences Inc. (NASDAQ:EVFM) Finding Zero Support

Evofem Biosciences Inc. (EVFM) shares are trading at lower $2.26 and the avg recommendation for the stock is Moderate Buy. To add more color...

Mattel Inc. (NASDAQ:MAT) on the Path to Profitability

Mattel Inc. (MAT) shares are trading at higher $15.71 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Baidu Inc. (NASDAQ:BIDU) Recent Earnings Shows Major Promise

Baidu Inc. (BIDU) shares are trading at higher $136.00 and the avg recommendation for the stock is Moderate Buy, while the current analyst price...

Can We Expect More Volatility From Gores Metropoulos Inc. (GMHI)?

Gores Metropoulos Inc. (GMHI) shares are trading at lower $13.59. To add more color to this target, the company’s high over the last year...

Synchrony Financial (SYF) shares are trading at higher $29.38 and the avg recommendation for the stock is Strong Buy, while the current analyst price target stands at $31.03.

To add more color to this target, the company’s high over the last year is $38.18 and the low is $12.15. Over the last 52 weeks, SYF is down -13.54% while the S&P 500 is up 16.04%. The catalyst for this interesting swing was the company’s recent earnings report.

A Notable Earnings Report

In the last quarter, SYF reported a profit of $3.4 billion. Synchrony Financial also saw revenues increase to $3.83 billion. In addition, SYF has free cash flow of $3.92 billion as of 06-2020.

SYF booked profit margins of 11.80%, its Return on Equity (ROE) is 16.20%, and its Return on Assets is 2.10%. All told, it is clear that, SYF needs to be on your watchlist.

Find out when SYF reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.

Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. SYF has a short ratio of 2.89 and outstanding shares of 583.70M.

Company Outlook

SYF has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 3.73 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 3.26. Investors should also keep an eye on sector updates as SYF has historically followed its peers on positive news.

All told, Synchrony Financial SYF has strung together solid data and demonstrated underlying fundamentals. At its current valuation, SYF represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.

Synchrony Financial SYF is now commanding a market cap of 16.99B and a float of 581.24M. SYF is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of SYF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in SYF, either long or short, and we have not been compensated for this article.

Latest article

Juniper Networks Inc. (NYSE:JNPR) Stock is Plummeting, Here is Why

Juniper Networks Inc. (JNPR) shares are trading at lower $22.04 and the avg recommendation for the stock is Moderate Buy, while the current analyst...

Chindata Group Holdings Limited (CD)’s Stock is Jumping, Here is Why

Chindata Group Holdings Limited (CD) shares are trading at higher $18.94. To add more color to this target, the company’s high over the last...

Can We Expect More Volatility From BOQI International Medical Inc. (BIMI)?

BOQI International Medical Inc. (BIMI) shares are trading at higher $2.09. To add more color to this target, the company’s high over the last...

When Will Diffusion Pharmaceuticals Inc. (DFFN) Slow Down

Diffusion Pharmaceuticals Inc. (DFFN) shares are trading at higher $0.78. To add more color to this target, the company’s high over the last year...

EyePoint Pharmaceuticals Inc. (NASDAQ:EYPT) is Gaining Momentum on Earnings Catalyst

EyePoint Pharmaceuticals Inc. (EYPT) shares are trading at higher $0.47 and the avg recommendation for the stock is Moderate Buy. To add more color...